Fate Therapeutics Insider Trades

FATE

Track insider trading activity from Fate Therapeutics executives and directors. See which insiders are buying and selling FATE stock.

Trades Last 12 Months

FATE Price

All Insider Trades for Fate Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Valamehr Bahram President And CEO
Holding Value $1.41M 635,762 shares
Last Trade
May 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$54.4k 28,946 shares
$1.88
$2.22
Tahl Cindy See Remarks
Holding Value $1.39M 628,155 shares
Last Trade
May 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$48.1k 25,590 shares
$1.88
$2.22
Holding Value $0 0 shares
Last Trade
May 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59k 25,000 shares
$2.36
$2.22
Epstein Robert S Director
Holding Value $0 0 shares
Last Trade
May 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59k 25,000 shares
$2.36
$2.22
Redmile Group, Llc 10% owner
Holding Value $8.64M 3,893,674 shares
Last Trade
Apr 20, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$5.13M 3,691,324 shares
$1.39
$2.22
Adawi Kamal Chief Financial Officer
Holding Value $222k 100,000 shares
Last Trade
Jan 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$105k 100,000 shares
$1.05
$2.22
Holding Value $19.9M 8,977,624 shares
Last Trade
Jul 02, 2025 Sale
$298k 266,280 shares
$1.12
$2.22
Xu Yuan Director
Holding Value $122k 55,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.6k 55,000 shares
$1.32
$2.22
Agarwal Shefali Director
Holding Value $122k 55,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.6k 55,000 shares
$1.32
$2.22
Jooss Karin Director
Holding Value $122k 55,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.6k 55,000 shares
$1.32
$2.22
Holding Value $122k 55,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.6k 55,000 shares
$1.32
$2.22
Mendlein John Director
Holding Value $122k 55,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.6k 55,000 shares
$1.32
$2.22
Holding Value $122k 55,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.6k 55,000 shares
$1.32
$2.22
Bressi Jerome Charles See Remarks
Holding Value $744k 335,203 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$330k 250,000 shares
$1.32
$2.22
Coughlin Timothy Director
Holding Value $88.8k 40,000 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147k 40,000 shares
$3.68
$2.22
Dulac Edward J Iii Chief Financial Officer
Holding Value $225k 101,479 shares
Last Trade
Mar 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$19k 2,447 shares
$7.77
$2.22
Wolchko J Scott President And CEO
Holding Value $1.11M 500,000 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.38M 500,000 shares
$6.76
$2.22
Powl Brian T. Chief Commercial Officer
Holding Value $91.3k 41,146 shares
Last Trade
Jul 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.8k 3,854 shares
$4.87
$2.22
Hershberg Robert Director
Holding Value $88.8k 40,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 40,000 shares
$5.52
$2.22
Chu Yu Waye Chief Medical Officer
Holding Value $317k 142,993 shares
Last Trade
Apr 18, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.6k 2,532 shares
$6.57
$2.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up